Objective: Colorectal cancer screening (CRCS) should be a necessary part of gynecology (GYN) providers' preventive practices. The purpose of our study is to examine CRCS recommendations and adherence in this population. Methods: A questionnaire was administered to a prospective cohort of patients awaiting health maintenance exams at six academic and private gynecology offices. Patients reported demographics, CRC=breast=cervical screening adherence, CRCS recommendations, and future likelihood of CRCS. Results: A total of 461 women aged 51 years and older completed the questionnaire. Sixty-six percent of respondents were compliant with CRCS compared to 93% and 86% for breast and cervical cancer screening, respectively ( p < 0.001). GYN providers recommended CRCS in 43% of patients. Sixty-three percent were planning to undergo future CRCS. On multivariable analysis, characteristics associated with CRCS adherence included (odds ratio, 95% confidence interval): older age (1
Introduction

I
n 2008, it is expected that colorectal cancer (CRC) will account for 148,810 new diagnoses and 49,960 deaths. 1 Despite the implementation of CRC screening guidelines published jointly since 1997 by the American College of Gastroenterology, the U.S. Preventive Services Task Force and the American Cancer Society, patient compliance for CRC screening remains suboptimal. [2] [3] [4] Data from the Behavioral Risk Factor Surveillance System (BRFSS) revealed that only 57% of the U.S. population is adherent to CRC screening guidelines. 5 In order to improve CRC screening compliance, we must investigate all populations in the primary care realm. For women, gynecologists are an important source of primary care, particularly for annual preventive care. Their gynecologist may be the only physician that they come into contact with. Anywhere between 37 to 93% of obstetrician=gynecologists (ob=gyn) consider themselves to be primary care health providers. [6] [7] [8] The National Ambulatory Medical Care Survey (NAMCS) and the National Hospital Ambulatory Care Survey (NHACS) collected information on care provided by office-based physicians and outpatient clinics in a nationally representative sample of healthcare visits and showed that 1 Division of Gastroenterology, University of Michigan, Ann Arbor, Michigan. 2 Division of Gastroenterology, University of California-San Francisco, San Francisco, California. 3 Division of Obstetrics=Gynecology, University of Michigan, Ann Arbor, Michigan. 10.1089=jwh.2009.1479 primary care visits to obstetricians=gynecologists account for 45 million office visits and 4 million outpatient clinic visits. 9 The Residency Review Committee for Obstetrics-Gynecology recognized this important finding and recommended a minimum of 6 months of primary care within 4 years of obstetrics=gynecology residency training, which was implemented by the Accreditation Council for Graduate Medical Education in 1996. 10 As a part of the annual maintenance examination for Ob= Gyn, CRC screening should be addressed in age-appropriate women. 11 However, few studies in the gynecology literature have addressed CRC screening adherence in their patients. One study revealed the primary method of CRC screening by obstetricians=gynecologists was flexible sigmoidoscopy, followed by a fecal occult blood test (FOBT). 12 Data collected from the National Heath Interview Survey reported that 43% of women aged 50-64 seeing gynecologists underwent colorectal cancer screening, compared to cervical cancer screening and mammography at 97% and 90.9%, respectively. 13 With more reliable techniques that have proven effective in reducing colon cancer mortality, it is necessary to focus our efforts on this population to evaluate their CRC screening adherence, and thus possibly improve the overall CRC screening rate. [14] [15] [16] [17] [18] [19] [20] [21] [22] The aims of this study were to compare rates of adherence to screening for CRC versus other malignancies recommended for women seen in gynecology clinics for routine health maintenance exams, and to examine the effect of CRC screening recommendations from gynecology and other providers on current adherence and intention to undergo CRC screening in the future.
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Methods
This study was conducted in Ann Arbor, Michigan, at three outpatient clinics in the University of Michigan Health System and three unaffiliated, private obstetrics=gynecology clinics in the Detroit metropolitan area. The three outpatient academic clinics represent 24 providers. Two of the three private clinics were single specialty; the remaining practice was multispecialty, representing 10 providers in all. With institutional review board approval, female patients were solicited for enrollment in the offices' waiting room prior to routine health maintenance examinations (HME). Patients were consecutively enrolled among all eligible patients seen in each clinic setting. Appointments with both board-certified gynecologists and nurse-practitioners (NP) (collectively, GYN providers) were included, since nurse-practitioners are utilized as physician extenders in ob=gyn practices and routinely perform HMEs. Resident clinics were specifically not solicited. Participants aged 51 and older were eligible for participation. Participating subjects were required to have an established relationship with the practice, which was defined by at least one health maintenance appointment in the preceding year. Exclusion criteria included new patients and gastrointestinal disorders requiring periodic endoscopic surveillance of the colon.
Our planned sample size of 400 subjects was based on an alpha of 0.05, with a 95% power to detect a 10% difference in adherence between CRC screening and breast or cervical cancer screening.
Consenting subjects completed an anonymous survey based on constructs from validated surveys and in our previous work. 23, 24 (Appendix 1) Patient demographic data were obtained including the subjects' age, and marital and employment status. The patients' insurance status, gender, and type of practitioner were also noted. Participants were asked whether they considered their GYN provider to be their primary care provider. Current CRC screening status (adherence) was assessed at the time of the survey if they had completed FOB testing in the last 12 months, a flexible sigmoidoscopy or double contrast barium enema in the last five years, or colonoscopy in the last ten years. Questions assessing adherence to other preventive health behaviors, i.e., breast and cervical cancer screening, were included. Participants were specifically asked if their GYN provider, PCP, or another physician had recommended CRC screening. We also assessed the subjects' intentions to undergo CRC screening in the future. Personal experience with CRC was derived from the subjects' personal knowledge of someone with CRC and a family history of CRC.
Statistical Analysis
The response rate was defined as the ratio between the number of subjects who completed the entire study survey and the number of patients solicited for entry in the study. Chi-square or Student's t-test were used to assess the relationship between the independent variable (recommendation of CRC screening) and the dependent variables (current CRC screening adherence and intended future CRCS screening), in addition to a comparison of screening rates between CRC and cervical or breast cancer. The following variables were utilized for both univariate analyses: insurance, age, female= male physician, each type of ethnicity, marital status, employment status, gynecologist only, PCP only, gynecologist plus PCP, previous mammography cervical cancer screening, and previous CRC screening. The multivariable regression analysis was used to simultaneously adjust the model for the effects of independent variables that were identified to be significantly associated in univariate analysis ( p < 0.05). In the multivariable regression analysis, p values < 0.05 were considered significant, and the results are presented as odds ratios with 95% confidence intervals.
Results
Characteristics of the study population
A total of 461 women were solicited and enrolled in the study at the time of their health maintenance exam. Complete data were available for 438 participants (95% response rate). The majority of participants were seen by ob=gyns (72%) with the remaining patients seen by nurse-practitioners. Characteristics of the study population are described in Table 1 . Overall, most respondents were Caucasian (90%), married (69%), and employed (61%). The mean age was 58 AE 6.7 years. Fifty-three percent were participants from an academic practice. Twenty-one percent of subjects identified their GYN as their primary care provider.
CRC screening recommendations
Forty-three percent of participants reported CRC screening recommendations from their GYN provider. The private population that we surveyed reported a CRC screening recommendation rate of 47% vs. 40% in the academic population.
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Overall, 75% of participants reported a previous CRC screening recommendation from any physician. Fifty-nine percent of participants reported that their PCP had given them a prior CRC screening recommendation.
CRC screening adherence
Sixty-six percent of all respondents stated prior compliance with one or more CRC screening modalities, which was significantly lower than compliance to breast (93%) and cervical cancer screening (86%, p < 0.001 for all comparisons). Participants were more compliant with CRC screening in the academic setting (76%) vs. the private setting (55%). Colonoscopy (53%) was the most frequently utilized modality for participants. An additional 17.5% and 11.5% had fecal occult stool and flexible sigmoidoscopy performed, respectively. Of the 43% of subjects who reported that their gynecologists advised them to undergo CRC screening, 76% of these patients were adherent for CRC screening.
Predictors of CRC screening adherence
Significant patient characteristics predictive of CRC screening adherence at the time of the survey in multivariable analysis (Table 2 ) included older age, previous mammography, family history of CRC=polyps, a friend with CRC, and any physician (defined as GYN provider, internal medicine= family practice, or other physician) recommending CRC screening. CRCS rates were higher among patients who received a recommendation from a PCP than from a GYN provider Patients in the academic setting were two-fold more likely than those in nonacademic settings to have previously undergone any CRC screening test at the time of the survey.
Future CRC screening
Sixty-three percent of respondents were planning to undergo CRC screening in the future. In those participants who had undergone CRC screening previously, 72% planned future CRC screening vs. 51% of respondents who had not undergone CRC screening at the time of the HME. Predictors of intention to screen in the future (Table 3) in the multivariable analysis include previous mammography, any doctor recommendation, and FH of CRC=polyps. CRC screening recommendations by both GYN providers and PCPs had a greater impact on future CRC screening contemplation than those from a PCP or GYN provider alone. There was no difference in participants' likelihood to undergo future CRC screening based on practice setting.
Discussion
Despite preventive modalities that have been shown to reduce CRC mortality, CRC screening adherence remains low. This study examined CRC screening recommendations from different providers, and adherence and intention to undergo CRC screening in the future among gynecology patients at the time of their HME. Our findings demonstrate a CRC screening rate for our population that is better than the national average; however, CRC screening adherence was significantly lower than adherence to breast and cervical cancer screening. Only slightly more than 40% of women reported CRC screening recommendations from their gynecologic provider. In past studies, GYN providers have been shown to be less likely to recommend CRC screening than internists and family practitioners. 25, 26 Possibly the routine use of a FOBT during the gynecologic examination was felt to obviate the need for GYN providers to discuss CRC screening. Musinski demonstrated that 37% of patients being seen for a HME had a FOBT with the examiner's glove as their only source for CRC screening. 12 In a recent survey of gynecologists and nursepractitioners, FOBT was the preferred CRC screening modality, with 30% using in-office single FOBT solely. Collins et al. demonstrated that only 4.9% of patients with cancer or large polyps had a positive FOBT from a single sample of stool obtained during the rectal examination, emphasizing that a single FOBT performed in the office via digital rectal exam is not an acceptable CRC screening option. 27 Regardless, close to 60% of our cohort reported no CRC screening recommendations from their GYN provider. This is important given that one in five women considered their GYN provider to be their only source for preventive care.
The likelihood of prior and intention to undergo future CRC screening at the time of the survey was directly correlated with physician recommendation. Several studies have cited physician recommendation as an important factor influencing a patient decision to undergo CRC screening. [28] [29] [30] [31] [32] [33] [34] Weitzman et al. demonstrated that persistent recommendations and a strong personal directive from a physician increased the use of FOBT and flexible sigmoidoscopy, even overcoming reluctance for screening. 34 In women aged 50 to 80, Mandelson et al demonstrated that physician encouragement was the strongest factor related to participation in CRC screening. 30 Interestingly, increased CRC screening adherence was seen with a specific type of provider in our study. Patients were particularly adherent when their PCP recommended CRC screening. Our finding may be secondary to patients' visiting their PCP more often than their gynecologist, thus giving the PCP more opportunity for CRC prevention. This demonstrates that the usual source of care is crucial for CRC screening adherence. 35, 36 Additionally, the PCPs in our study may have had a better infrastructure for scheduling CRC screening modalities, thus improving their effectiveness in CRC screening adherence. More importantly, our study demonstrates the additive effect of multiple CRC screening recommendations by different providers on future CRC screening contemplation. Data from the National health Interview Survey were consistent with our findings that the combination of general medical physician and gynecologist care increased the probability of women receiving CRC screening. 13 This reiterates the need for all physicians to take advantage of every patient contact and seize this teachable moment to prompt individuals to undergo CRC screening and enhance compliance.
In our subjects, other positive predictors for current CRC screening adherence and intention to undergo future CRC screening included family history of CRC or a patient's knowledge of someone with CRC or both. Our findings are consistent with data reported in the literature. 32, [36] [37] [38] [39] [40] [41] [42] [43] The strongest data comes from three multivariable analyses. 31, 38, 43 Codori et al. demonstrated that the extent of family history with the number and proportion of first-degree relatives was predictive of endoscopic screening. 38 In a survey of subjects with a first-degree relative of CRC, Harris and Byles showed that having more than one relative with colorectal cancer and being a sibling of the relative with colon cancer were associated with compliance with any of the accepted CRC screening modalities. 37 Finally, Manne et al. demonstrated that CRC screening compliance was associated with the closeness of the emotional tie with the affected sibling. 43 It was postulated that the closer the relationship with the affected sibling, the more likely the affected sibling would advise CRC screening and the more likely the healthy sibling would be influenced by this recommendation.
Previous studies have demonstrated that other non-CRCrelated screening tests, such as mammography, Pap smear, and prostate-specific antigen utilization within the past year, are associated with improved CRC screening among patients. 41, [44] [45] [46] In our population, both mammography and cervical screening were predictive of CRC screening on univariate analysis. However, adjusting for other predictive factors, only mammography remained significant. Nationally, our mammography compliance rate far exceeded the data from the 2006 BRFSS, which reported a 79.9% compliance rate for mammography in women aged 50 and older. 47 Our study has several notable potential limitations. The primary limitation of our study is that it relied on participant self-report; therefore, recall bias may be introduced by the study design. Participants may have overestimated their CRC, breast, and cervical cancer screening compliance rates. Additionally, patients may have incorrectly recalled their discussions regarding CRC screening with their providers. In our patient population we did not assess the lifetime experience for CRC screening. We only assessed the participants' current CRC screening adherence at the time of the survey. Factors related to future CRC screening in the adherent vs. ever undergoing some type of CRC screening vs. those who have not undergone CRC screening may be different. This is an area for future study. Lastly, our study may not be able to be generalized to all women since our population was fairly homogenous and our sample was obtained at both academic offices and specific private practice offices that were willing to participate with the study.
In summary, among patients attending outpatient gynecology appointments, adherence to CRC screening is significantly lower than to breast and cervical cancer screening. Having multiple providers recommend CRC screening increases gynecology patients' likelihood of undergoing future CRC screening. However, CRC screening compliance is primarily driven solely by PCP recommendations. Regardless, strategies must be in place to prompt gynecologists and nurse-practitioners to discuss CRC screening in eligible patients. With new efforts, gynecologists may help improve CRC screening compliance in their female patients.
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